Cape Verde vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Cape Verde
100.0%
in 2024
South-East Asia (WHO region)
94.0%
in 2024
Cape Verde rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cape Verde
- South-East Asia (WHO region)
How they compare
Cape Verde currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Cape Verde's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 6 times across 14 shared years of data; in 2005 it was Cape Verde ahead.
Cape Verde ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Across the 3 decades both report, Cape Verde averaged higher in 2 and South-East Asia (WHO region) in 1.
Head to head by decade
| Decade | Cape Verde | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 5.6% | 94.4% | Cape Verde |
| 2010s | 93.6% | 80.5% | 13.1% | Cape Verde |
| 2020s | 90.4% | 92.2% | 1.8% | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cape Verde or South-East Asia (WHO region)?
- Cape Verde, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cape Verde and South-East Asia (WHO region)?
- 6.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and South-East Asia (WHO region)?
- 14 years are reported by both, from 2005 to 2024.
- How do Cape Verde and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cape Verde ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.